[
  {
    "ts": "2026-02-05T03:08:35+00:00",
    "headline": "AbbVie Q4 Earnings Call Highlights",
    "summary": "AbbVie (NYSE:ABBV) executives said the company closed 2025 with record revenue and earnings above initial expectations, citing strong performance from its “ex-Humira growth platform,” continued momentum for Skyrizi and Rinvoq, and expanding contributions from neuroscience and other franchises. On t",
    "url": "https://www.marketbeat.com/instant-alerts/abbvie-q4-earnings-call-highlights-2026-02-04/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "2f02ce2f-6118-371f-8c71-c28922ffed8f",
      "content": {
        "id": "2f02ce2f-6118-371f-8c71-c28922ffed8f",
        "contentType": "STORY",
        "title": "AbbVie Q4 Earnings Call Highlights",
        "description": "",
        "summary": "AbbVie (NYSE:ABBV) executives said the company closed 2025 with record revenue and earnings above initial expectations, citing strong performance from its “ex-Humira growth platform,” continued momentum for Skyrizi and Rinvoq, and expanding contributions from neuroscience and other franchises. On t",
        "pubDate": "2026-02-05T03:08:35Z",
        "displayTime": "2026-02-05T03:08:35Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/d14f178b61e5d1b3f07aed92c6bf5868",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "AbbVie logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lCHq.E1saNbd6P5A_hygCw--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/d14f178b61e5d1b3f07aed92c6bf5868.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jidNKNPfHTagH3j2JawAnw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/d14f178b61e5d1b3f07aed92c6bf5868.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/instant-alerts/abbvie-q4-earnings-call-highlights-2026-02-04/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-q4-earnings-call-highlights-030835847.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T05:32:45+00:00",
    "headline": "ABBV Q4 Deep Dive: Immunology and Neuroscience Growth Offset Aesthetics Softness and Pricing Headwinds",
    "summary": "Pharmaceutical company AbbVie (NYSE:ABBV) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 6% year on year to $16 billion. Its non-GAAP profit of $2.71 per share was 2.2% above analysts’ consensus estimates.",
    "url": "https://finance.yahoo.com/news/abbv-q4-deep-dive-immunology-053245917.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "3ee31399-0ea8-36bb-8038-0ed4778b7d33",
      "content": {
        "id": "3ee31399-0ea8-36bb-8038-0ed4778b7d33",
        "contentType": "STORY",
        "title": "ABBV Q4 Deep Dive: Immunology and Neuroscience Growth Offset Aesthetics Softness and Pricing Headwinds",
        "description": "",
        "summary": "Pharmaceutical company AbbVie (NYSE:ABBV) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 6% year on year to $16 billion. Its non-GAAP profit of $2.71 per share was 2.2% above analysts’ consensus estimates.",
        "pubDate": "2026-02-05T05:32:45Z",
        "displayTime": "2026-02-05T05:32:45Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/621a415265c388bc8e9eb8ecaf0fb0a8",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "ABBV Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/K222hrzb0FJJlqrDZzsz7w--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/621a415265c388bc8e9eb8ecaf0fb0a8.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cD3IChyAhZhexmnMXW7jMA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/621a415265c388bc8e9eb8ecaf0fb0a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbv-q4-deep-dive-immunology-053245917.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbv-q4-deep-dive-immunology-053245917.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T14:00:52+00:00",
    "headline": "Morning Movers: Eli Lilly rises, Boston Scientific falls after quarterly results",
    "summary": "Stock futures are mixed and have shown modest signs of stabilization after a sharp downturn in software and AI-related technology stocks yesterday, prompting some investors to treat the technology selloff that pressured equities broadly as a buying opportunity. Against that backdrop, defensive sectors and commodity-linked assets have drawn interest, particularly as gold reclaimed levels above $5,000 an ounce, reflecting continued demand for safe havens amid uncertainty. Claim 50% Off TipRanks Pr",
    "url": "https://finance.yahoo.com/news/morning-movers-eli-lilly-rises-140052306.html",
    "source": "TipRanks",
    "provider": "yfinance",
    "raw": {
      "id": "ed66cd00-8d90-3e73-9d2a-c99e7d64e7e8",
      "content": {
        "id": "ed66cd00-8d90-3e73-9d2a-c99e7d64e7e8",
        "contentType": "STORY",
        "title": "Morning Movers: Eli Lilly rises, Boston Scientific falls after quarterly results",
        "description": "",
        "summary": "Stock futures are mixed and have shown modest signs of stabilization after a sharp downturn in software and AI-related technology stocks yesterday, prompting some investors to treat the technology selloff that pressured equities broadly as a buying opportunity. Against that backdrop, defensive sectors and commodity-linked assets have drawn interest, particularly as gold reclaimed levels above $5,000 an ounce, reflecting continued demand for safe havens amid uncertainty. Claim 50% Off TipRanks Pr",
        "pubDate": "2026-02-05T14:00:52Z",
        "displayTime": "2026-02-05T14:00:52Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/tipranks_452/097670a128888e1828116a13ce464258",
          "originalWidth": 192,
          "originalHeight": 192,
          "caption": "https://www.tipranks.com/news/the-fly/morning-movers-eli-lilly-rises-boston-scientific-falls-after-quarterly-results-thefly",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/paL.s16_PAor.Ex2OGgnDQ--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/097670a128888e1828116a13ce464258.cf.webp",
              "width": 192,
              "height": 192,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Z7N7z9dCk4A19oWcLwtVRQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/097670a128888e1828116a13ce464258.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "TipRanks",
          "url": "https://www.tipranks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/morning-movers-eli-lilly-rises-140052306.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/morning-movers-eli-lilly-rises-140052306.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "FOX"
            },
            {
              "symbol": "FOXA"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "CMG"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "FTV"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "CTSH"
            },
            {
              "symbol": "EFX"
            },
            {
              "symbol": "SLAB"
            },
            {
              "symbol": "TXN"
            },
            {
              "symbol": "JCI"
            },
            {
              "symbol": "YUM"
            },
            {
              "symbol": "UBER"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "GEHC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T13:48:00+00:00",
    "headline": "Does Ironwood's Bullish 2026 View Signal Greater Linzess Adoption?",
    "summary": "IRWD expects Linzess demand to accelerate, driving a bullish 2026 outlook with revenue growth, higher profits and expanding adoption.",
    "url": "https://finance.yahoo.com/news/does-ironwoods-bullish-2026-view-134800072.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "b8a44fb2-7d95-338b-b29f-1dff155302e8",
      "content": {
        "id": "b8a44fb2-7d95-338b-b29f-1dff155302e8",
        "contentType": "STORY",
        "title": "Does Ironwood's Bullish 2026 View Signal Greater Linzess Adoption?",
        "description": "",
        "summary": "IRWD expects Linzess demand to accelerate, driving a bullish 2026 outlook with revenue growth, higher profits and expanding adoption.",
        "pubDate": "2026-02-05T13:48:00Z",
        "displayTime": "2026-02-05T13:48:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/5d53490d96d857e2597369efd142a916",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HT9dcJW2gBb88_fWbEkPdQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d53490d96d857e2597369efd142a916.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5ysuZYz59NJOpcHkYE2XYA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d53490d96d857e2597369efd142a916.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/does-ironwoods-bullish-2026-view-134800072.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/does-ironwoods-bullish-2026-view-134800072.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "ALPMF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T12:58:00+00:00",
    "headline": "Rapid Innovation is Reshaping Oncology: Stocks in Focus",
    "summary": "Rapid advances in immunotherapy, targeted drugs & artificial intelligence-driven research are reshaping oncology, spotlighting select cancer stocks to watch now.",
    "url": "https://finance.yahoo.com/news/rapid-innovation-reshaping-oncology-stocks-125800121.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "eea53401-fba1-35aa-b85a-bb0eed5f6778",
      "content": {
        "id": "eea53401-fba1-35aa-b85a-bb0eed5f6778",
        "contentType": "STORY",
        "title": "Rapid Innovation is Reshaping Oncology: Stocks in Focus",
        "description": "",
        "summary": "Rapid advances in immunotherapy, targeted drugs & artificial intelligence-driven research are reshaping oncology, spotlighting select cancer stocks to watch now.",
        "pubDate": "2026-02-05T12:58:00Z",
        "displayTime": "2026-02-05T12:58:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/675c0ae70cb5036ad2ceb9062f13afc2",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zhUbp770QgvNMyXdM9XKnA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/675c0ae70cb5036ad2ceb9062f13afc2.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ii2rwaxi8Dao2zrk4I.W2Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/675c0ae70cb5036ad2ceb9062f13afc2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/rapid-innovation-reshaping-oncology-stocks-125800121.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/rapid-innovation-reshaping-oncology-stocks-125800121.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "RCUS"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T14:00:03+00:00",
    "headline": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
    "summary": "The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.",
    "url": "https://finance.yahoo.com/news/2-medical-stocks-could-beat-140003707.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "c3d7060c-4c5d-3e1e-86d9-b5bf0d6a4902",
      "content": {
        "id": "c3d7060c-4c5d-3e1e-86d9-b5bf0d6a4902",
        "contentType": "STORY",
        "title": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
        "description": "",
        "summary": "The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.",
        "pubDate": "2026-02-05T14:00:03Z",
        "displayTime": "2026-02-05T14:00:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/26a86d59f0e8f1e82a35a92ae5684cd9",
          "originalWidth": 900,
          "originalHeight": 845,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EqK8ApWUE5x_2yrT2tcofA--~B/aD04NDU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/26a86d59f0e8f1e82a35a92ae5684cd9.cf.webp",
              "width": 900,
              "height": 845,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/echl9KTe6EOuSV3hwRYFlw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/26a86d59f0e8f1e82a35a92ae5684cd9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/2-medical-stocks-could-beat-140003707.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-medical-stocks-could-beat-140003707.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "INSP"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]